Azenta Inc (AZTA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Storia dei dividendi

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Azenta Inc Stock (AZTA) Company Profile

Healthcare (1170)

(978) 262-2400

200 SUMMIT DRIVE, BURLINGTON

Prossima data di guadagno

Ultimi documenti SEC

AZTA's Discussions on Twitter

Confronta AZTA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AZTA Azenta Inc	28.75	1.22B	656.32M	-164.17M	12.90M	-2.9794
ISRG Intuitive Surgical Inc	557.08	197.97B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	173.45	49.82B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	87.79	42.51B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	252.20	35.89B	5.02B	1.31B	1.56B	8.91
BAX Baxter International Inc	30.26	15.65B	11.89B	-560.00M	191.00M	-1.10

Azenta Inc Stock (AZTA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-18	Aggiornamento	Stephens	Equal-Weight → Overweight
2024-04-04	Iniziato	Jefferies	Hold
2024-02-01	Reiterato	B. Riley Securities	Buy
2023-07-19	Iniziato	Raymond James	Mkt Perform
2023-05-10	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2023-02-09	Downgrade	Stephens	Overweight → Equal-Weight
2023-01-03	Downgrade	Evercore ISI	Outperform → In-line
2022-03-31	Ripresa	B. Riley Securities	Buy
2022-03-21	Iniziato	Evercore ISI	Outperform

Mostra tutto

Azenta Inc Borsa (AZTA) Ultime notizie

Azenta Inc Azioni (AZTA) Dati Finanziari

Azenta Inc Azioni (AZTA) insider trading

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Zhou Ginger	SVP and General Manager, Genom	Jan 31 '25	Buy	45.88	417	19,132	27,916
Pirogova Olga	SVP and CHRO	Nov 19 '24	Sale	40.07	548	21,958	19,373
Hughes Violetta	VP, Chief Accounting Officer	Nov 19 '24	Sale	40.07	163	6,531	9,920
Zhou Ginger	SVP and General Manager, Genom	Nov 19 '24	Sale	40.07	491	19,674	27,499
Wang David Dong	SVP & GM, SMS	Nov 19 '24	Sale	40.07	348	13,944	24,114
Joseph Jason	SVP, General Counsel, Secy.	Nov 19 '24	Sale	40.07	1,139	45,640	112,564
Cueto Herman	EVP, Chief Financial Officer	Nov 19 '24	Sale	40.07	712	28,530	23,892
Marotta John	President and CEO	Nov 18 '24	Buy	39.48	12,717	502,066	99,612
Marotta John	President and CEO	Nov 19 '24	Buy	40.67	1,250	50,838	100,862
Cornog William L	Director	Nov 18 '24	Buy	39.60	12,500	495,000	14,755

Azenta Inc (AZTA)

Azenta Inc Stock (AZTA) Company Profile

Confronta AZTA con altri titoli

Azenta Inc Stock (AZTA) Upgrades & Downgrades

Azenta Inc Borsa (AZTA) Ultime notizie

Azenta, Inc. (NASDAQ:AZTA) Shares Acquired by Deutsche Bank AG - Defense World

Cetera Investment Advisers Sells 539 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World

Millennium Management LLC Purchases 17,899 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World

Is Now An Opportune Moment To Examine Azenta, Inc. (NASDAQ:AZTA)? - Yahoo

Azenta, Inc. (NASDAQ:AZTA) Position Lessened by Man Group plc - Defense World

Enhance Laboratory Efficiency with Azenta’s CryoPod Carrier - Lab Manager

Ameriprise Financial Inc. Increases Holdings in Azenta, Inc. (NASDAQ:AZTA) - Defense World

Captrust Financial Advisors Acquires 2,026 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World

The Manufacturers Life Insurance Company Has $447,000 Holdings in Azenta, Inc. (NASDAQ:AZTA) - Defense World

Azenta Announces Leadership Change with New General Counsel - TipRanks

Azenta Life Sciences and Form Bio Announce Strategic Partnership - GuruFocus

Northern Trust Corp Reduces Stake in Azenta, Inc. (NASDAQ:AZTA) - Defense World

Azenta (AZTA) Partners with Form Bio to Advance AAV Gene Therapy - GuruFocus

Azenta, Form Bio Launch Partnership for AAV Gene Therapy - marketscreener.com

Azenta Life Sciences And Form Bio Announce Strategic Partnership To Advance AAV Gene Therapy Development - marketscreener.com

Azenta, Form Bio announce strategic partnership - TipRanks

Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development - Nasdaq

Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Voya Investment Management LLC - Defense World

Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know - Yahoo Finance

Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023 - Seeking Alpha

AZTA Q1 Earnings Call: Revenue Tops Expectations, Margin Progress Amid Macro Headwinds - FinancialContent

Price T Rowe Associates Inc. MD Increases Stock Holdings in Azenta, Inc. (NASDAQ:AZTA) - The AM Reporter

Needham & Company LLC Lowers Azenta (NASDAQ:AZTA) Price Target to $40.00 - Defense World

Balance Sheet Insights: Azenta Inc (AZTA)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

Azenta targets 3%-5% organic growth and expands automation initiatives for FY2025 - MSN

Azenta, Inc. (NASDAQ:AZTA) Q2 2025 Earnings Call Transcript - Insider Monkey

First Trust Advisors LP Buys New Stake in Azenta, Inc. (NASDAQ:AZTA) - Defense World

Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic ... - Yahoo

Azenta (NASDAQ:AZTA) Hits New 1-Year Low Following Weak Earnings - Defense World

Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic Challenges - GuruFocus

Azenta, Inc. Reports Solid Q2 2025 Revenue Growth - TipRanks

Azenta, Inc. Reports Strong Q2 2025 Earnings - TipRanks

Azenta (AZTA) Price Target Lowered by Needham to $40 | AZTA Stoc - GuruFocus

Azenta Q2 2025 slides: Revenue growth returns with 400 bps margin expansion By Investing.com - Investing.com South Africa

Azenta (AZTA) Price Target Lowered by Needham to $40 | AZTA Stock News - GuruFocus

Transcript : Azenta, Inc., Q2 2025 Earnings Call, May 07, 2025 - marketscreener.com

Needham Adjusts Price Target on Azenta to $40 From $59, Keeps Buy Rating - marketscreener.com

Earnings call transcript: Azenta’s Q2 2025 results miss EPS forecast, stock rises - Investing.com Australia

Azenta Q2 2025 slides: Revenue growth returns with 400 bps margin expansion - Investing.com India

Azenta Fiscal Q2 Non-GAAP Earnings Fall, Revenue Rises - marketscreener.com

Azenta Surpasses Revenue Expectations in Q1 CY2025News and Statistics - IndexBox

Azenta (NASDAQ:AZTA) Beats Q1 Sales Targets - FinancialContent

Azenta (AZTA) Reports Q2 Earnings with Revenue Decline - GuruFocus

Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 | AZTA Stock News - GuruFocus

Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 - Quantisnow

Azenta expands PCR plate range - European Pharmaceutical Manufacturer

Azenta (AZTA) Q1 Earnings Report Preview: What To Look For - FinancialContent

S&P Dow Jones Indices Announces Changes to MidCap 400 and SmallCap 600 - SDx Central

Top investors say Azenta Inc (AZTA) ticks everything they need - Sete News

Examining Azenta Inc (AZTA) stock is warranted - uspostnews.com

Azenta Inc [AZTA] Insider Hughes Violetta sells 317 Shares - knoxdaily.com

Azenta Inc Azioni (AZTA) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Azenta Inc Azioni (AZTA) insider trading

Simile a AZTA